Exercise Capacity Is Improved by Levosimendan in Heart Failure and Sarcopenia via Alleviation of Apoptosis of Skeletal Muscle

BACKGROUND: Patients suffering from chronic heart failure (CHF) show an increased prevalence of sarcopenia. Levosimendan is an effective drug for the treatment of heart failure, but its effect on sarcopenia is still unclear. We aimed to explore whether levosimendan could enhance skeletal muscle cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Di, Song, Ming, Shen, Long-fei, Han, Lu, Zhu, Ping, Jia, Xu, Shang, Guo-kai, Cao, Yuan, Zhang, Wei, Zhong, Ming, Wang, Zhi-hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811365/
https://www.ncbi.nlm.nih.gov/pubmed/35126176
http://dx.doi.org/10.3389/fphys.2021.786895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811365/
https://www.ncbi.nlm.nih.gov/pubmed/35126176
http://dx.doi.org/10.3389/fphys.2021.786895

Ejemplares similares